← Back to All Filings

Precision Bio Officer Sells $8.5k in Stock for Tax Obligation

Low SignificanceNovember 3, 2025 at 3:32:16 PM EST

PRECISION BIOSCIENCES INC

$DTIL144CIK: 0001357874

Subscribe to track DTIL

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Precision Bio Officer Sells $8.5k in Stock for Tax Obligation

Company: PRECISION BIOSCIENCES INC (DTIL) Form: 144 | Filed: 2025-11-03 Significance: Low

Insider: Kelly John Alexander Title: Officer | Relationship: Officer

Transaction: • Type: Sale (Proposed) • Shares: 1,303 • Price: $6.49 • Value: $8,455 • Owned After: Not Disclosed

Key Insight: Low-significance proposed sale by an officer to cover tax obligations from a vested equity award. This is a routine, non-discretionary transaction and not indicative of a change in insider sentiment.

Market Context: The transaction represents a negligible fraction (<0.01%) of the company's market cap and shares outstanding.

Comprehensive Analysis

SEC Filing Analysis: PRECISION BIOSCIENCES INC (DTIL)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer filed a notice of proposed sale for a small number of shares to cover tax liabilities associated with vested stock awards.
  • Market Impact: Negligible. This type of transaction is routine and does not signal a change in insider outlook.

Company Information

FieldValue
CompanyPRECISION BIOSCIENCES INC
Ticker SymbolDTIL (Not in filing)
CIK0001357874
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameKelly John Alexander
CIK0001590030
Title/PositionOfficer
RelationshipOfficer

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-03 (Approximate Sale Date)
Transaction CodeNot Applicable
Security TypeCommon
Shares Involved1,303
Price Per Share$6.49 (approx.)
Total Value$8,455.17
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$8,455.17
% of Market Cap0.008%
Shares Transacted1,303
% of Shares Outstanding0.011%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The $8.5k transaction is immaterial against the company's $100 million market capitalization.
  • Transaction Significance: The sale is classified as 'Low' significance because it falls far below the materiality thresholds of 0.1% of market cap and 0.1% of shares outstanding.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a small, non-discretionary 'sell-to-cover' action for tax purposes, which carries no informational value about the company's future prospects.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares is too small to impact trading volume.
  • Sentiment Indicator: Neutral. This filing is unlikely to influence market sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's remarks explicitly state the purpose of the sale is to cover tax obligations resulting from the settlement of a vested equity award. This is a common and non-indicative insider transaction.
Topics:#SECFiling#InsiderTrading#DTIL#PrecisionBiosciences#Form144#StockMarket#Investing#FinancialAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.